Exact FDA event identifier

Event 98142

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 17, 2025
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: CareFusion 213, LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29

D-0243-2026

Recall number: D-0243-2026
Initiated: December 17, 2025
Classification: Class II
Status: Ongoing
Recalling firm: CareFusion 213, LLC
Quantity: 106,400 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Lack of Assurance of Sterlity

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterlity

Code information

Lot #: 5086623, Exp. Date 03/31/2028

Distribution pattern

Nationwide within the United States